Detecting Drug-Drug Interactions in COVID-19 Patients

COVID-19 patients with multiple comorbid illnesses are more likely to be using polypharmacy to treat their COVID-19 disease and comorbid conditions. Previous literature identified several DDIs in COVID-19 patients; however, various DDIs are unrecognized. This study aims to discover novel DDIs by con...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Eugene, Person, Anna K., Stollings, Joanna L., Su, Yu, Li, Lang, Chen, You
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208760/
https://www.ncbi.nlm.nih.gov/pubmed/35673029
http://dx.doi.org/10.3233/SHTI220090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208760/
https://www.ncbi.nlm.nih.gov/pubmed/35673029
http://dx.doi.org/10.3233/SHTI220090

Ejemplares similares